In a new study, scientists at the Max Planck Institute for Evolutionary Anthropology in Leipzig analyzed the impact of more ...

Large-scale drug atlas uncovers new genome editing modulators and potential therapeutic strategies for DNA repair-deficient cancers ...

These companies could innovate their way to success.

Because it requires so little to produce, the new strain could help bring more flavorful, environmentally friendly meat ...

Epithelial ovarian cancer (EOC) is an aggressive malignancy with limited therapeutic options. Poly(ADP-ribose) polymerase inhibitors (PARPi) have ...

In the big picture, matched sibling donor transplants remain the standard of care, Boelens said. But gene therapy is ...

Epithelial ovarian cancer (EOC) is an aggressive malignancy with limited therapeutic options. Poly(ADP-ribose) polymerase ...

CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...

Scientists from Kolkata-based Bose Institute have created GlowCas9 -- a CRISPR protein that lights up while performing gene ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

CSHL postdoc Miguel Santo Domingo Martinez and colleagues in the Lippman lab have used CRISPR gene editing to produce more ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...